Table 2.

Prevalence of genetic deletions in paired tumor and sputum samples from NSCLC patients

GeneNo. subjects with deletions (%)
Tumor, no. positive (%)Sputum, no. positive (%)
HYAL232/38 (84)17/38 (45)
FHIT30/38 (79)15/38 (40)
SP-C27/38 (71)0/38 (0)